PROTECTORProject for Reportability of Therapeutic Evaluations and Clinical Trials in Oncologic Research

Drs. Ludmir and Fuller will utilize natural-language processing (NLP) of clinical trials publications to augment and enrich records in ClinicalTrials.gov, affording the opportunity for large-scale analyses into patterns underlying trial success and accrual completion. Training and validation of NLP-based data extraction will be performed using previously-validated broad collections of cancer clinical trials.

Learn more about their work:

JAMA Network Open
Differential Treatment Effects of Subgroup Analyses in Phase 3 Oncology Trials From 2004 to 2020

Journal of Clinical Oncology – August 2024
Addition of Metastasis-Directed Therapy to Systemic Therapy for Oligometastatic Pancreatic Ductal Adenocarcinoma (EXTEND): A Multicenter, Randomized Phase II Trial